4//SEC Filing
Hopkins Janet Jill 4
Accession 0000950170-23-058900
CIK 0001501796other
Filed
Nov 2, 8:00 PM ET
Accepted
Nov 3, 5:04 PM ET
Size
7.1 KB
Accession
0000950170-23-058900
Insider Transaction Report
Form 4
Hopkins Janet Jill
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-11-01+200,000→ 200,000 totalExercise: $8.97Exp: 2033-10-31→ Common Stock (200,000 underlying) - Award
Common Stock
2023-11-01+135,000→ 135,000 total
Footnotes (2)
- [F1]These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Company's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Company's common stock. These RSUs vest in four substantially equal annual installments beginning on November 15, 2024, subject to the Reporting Person's continued service as of each such vesting date.
- [F2]The shares underlying this option vest as follows: 25% of the shares vest on October 16, 2024 with the remainder vesting thereafter in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date.
Documents
Issuer
Aura Biosciences, Inc.
CIK 0001501796
Entity typeother
Related Parties
1- filerCIK 0001997710
Filing Metadata
- Form type
- 4
- Filed
- Nov 2, 8:00 PM ET
- Accepted
- Nov 3, 5:04 PM ET
- Size
- 7.1 KB